Skip to main content
Release 2026.08DMD context observedDMD candidate-conditioned prediction not yet eligible
View scientific status
Evidence freeze: 3 August 2026Resource: v1.2.0-measured-dmd-evidenceSchema: 1.1Open release status
Explore NMD-VCell

Stable server-rendered gene record · v1.2.0-measured-dmd-evidence

DDX19B

Computational replication

G4 · muscle-context screen, not DMD replicationR2 · muscle-context bridge evidenceSupported · L2 observed same context perturbationAssessed · L3a external context screen

What this meansDDX19B has been experimentally perturbed in HepG2 cells, but it has not been independently perturbed in a DMD muscle model. Different DMD datasets do not completely agree on its disease-associated direction. The next useful step is computational replication—not a therapeutic claim.

通俗解释DDX19B已经在HepG2细胞中做过扰动,但尚未在DMD肌肉模型中独立验证。不同DMD数据集对它的疾病相关方向并不完全一致。下一步应完成能弥补当前证据缺口的受控实验,而不能把它直接称为治疗靶点。

Design the next experiment →
Prediction readinessR2 · muscle-context bridge evidence
Current evidenceObserved perturbation in the same HepG2 context
Additional contextAssessed · no current hit
Historical DMD prior (legacy)up
Source agreement1/2 sources

Gene Entity Page 2.1 · quantitative layer

Dataset-level evidence for DDX19B

Every row keeps its original context, metric and denominator. Empty fields remain explicit; no cross-source meta-effect is computed.

Download evidence JSON →
IdentityReleasedHGNC:2742 · ENSG00000157349
PerturbationMeasured in HepG2145 contributing cells
Muscle contextScreen assessed7.22865 TPM in skeletal muscle
DMD context2 source rowsDirectional conflict retained
DMD perturbation truthMissingNo independent DMD-muscle perturbation outcome
Calibrated predictionLockedR2 · no calibrated DMD response model
Dataset-level evidence rows for DDX19B
Dataset / evidenceContext and endpointObserved valueDenominator / supportState and source
HEPG2_CRISPRI_FROZEN_AGGREGATEperturbation observationEligible cells contributing to the frozen target-level aggregateHepG2; CRISPRi; non-muscle, non-DMD context145 cells145 cellsmeasuredOpen sourceObserved perturbation coverage in HepG2. The cells are not independent biological replicates and do not establish a DMD effect.
GTEX_V8_SKELETAL_MUSCLEexpression contextExpression feasibility contextHuman skeletal muscle tissue7.22865 TPM1 contexts · row count unavailablecontext onlyOpen sourceTissue expression supports assay feasibility only; it does not establish cell-type expression, function or perturbation response.
DEPMAP_CONTEXT_METRICdependency contextMedian gene-effect context metricDepMap cell-line dependency context; not muscle-specific-0.21244 DepMap gene-effect scoreDenominator not carriedcontext onlyOpen sourceA broad dependency context metric. It is not a safety result and is not evidence of disease-selective dependency.
HEPG2_CONTEXT_RELATIONSHIP_V06context relationshipContextual signature relationshipSame processed HepG2 perturbation substrate0.018132 unitless score145 cells contributing to the target aggregatecontext onlyOpen sourceA descriptive relationship within the same processed context; it is not therapeutic rescue or an independently validated effect.
GSE293514screen resultFusion-positive enrichmentHealthy human myoblast fusion CRISPR screen0.069099 log fold-changeFDR 0.9999991 contexts · 1 rows0 significant rowsassessed no hitOpen sourceHealthy-myoblast fusion endpoint only. A no-hit result is endpoint-specific and is not evidence of no muscle or DMD effect.
DMD single-cell baseline pseudobulkdisease context effectDisease-associated baseline expressionDMD skeletal-muscle single-cell source; baseline pseudobulk summaries0.22745 source-specific effect scaleMedian signed score 0.0000069717 contexts · 17 rows0 significant rowscontext onlyOpen sourceObserved-expression source summary; contextual evidence rather than candidate perturbation truth.
DMD single-cell delta / DIDdisease context effectDisease-associated change across declared contextsDMD skeletal-muscle single-cell source; final-label delta / DID summaries-0.215494 source-specific effect scaleMedian signed score -0.0000050618 contexts · 18 rows0 significant rowscontext onlyOpen sourceObserved-expression source summary; contextual evidence rather than candidate perturbation truth.

Source-specific effect display

DMD source-effect forest

Position is scaled to the largest absolute effect shown for this gene. Values remain on source-specific scales and are not pooled.

sc baseline pseudobulk+0.2274517 contexts · 0/17 significant rows
sc delta/DID-0.21549418 contexts · 0/18 significant rows
independent dmd muscle perturbationmissing not negativeUnlock: Run an independent, quality-controlled perturbation in a declared DMD-relevant human myogenic model with biological replication.
per gene deg pathway and cell state profilesource context summary only dmd perturbation missingUnlock: The v1.7 bridge publishes a HepG2 source-context summary and cross-DMD-source pathway projections. A disease-matched candidate perturbation with a biological denominator remains required.
calibrated dmd response predictionlockedUnlock: Accumulate prospective DMD perturbation outcomes and pass the registered calibration, applicability and external-validation gates.

Dataset rows preserve their original context and scale. They are not pooled into a causal effect, therapeutic rank or calibrated DMD prediction.

Frozen candidate bridge · PCB-v0.2-20260804

Cross-context DMD statistical bridge

Measured HepG2 response is compared with three separately measured DMD pathway axes. Individual source results come first; pooled values are exploratory descriptive summaries only.

Download all 21 rows →
Measured candidate DMD perturbations0/21
Validated candidate-level predictions0

Cross-context projection is not a measured DDX19B response in DMD muscle and does not establish rescue, efficacy, or a target rank.

HepG2 candidate / control cells145 / 4,976Cell-level exploratory comparison; no biological-replicate column.
Target-gene delta-0.141829Target present in the expression panel.
Exploratory DE rows26 rows at cell-level FDR < 0.05; donor/disease inference blocked.
Robust Reactome pathways00 up · 0 down of 1,378 tested.
Cross-DMD-source pathway projections for DDX19B
Measured DMD sourceDirect projection ρCascade projection ρStatistical unit and ceiling
GSE233606-0.086691,360 pathways-0.075881,360 pathwaysone line per condition3566 cells · descriptive unselected gene-axis concordance
GSE272233-0.102861,320 pathways-0.021881,320 pathways3 reported biological repeats per group21 samples · background-specific correction response
GSE2776370.13341,360 pathways0.191151,360 pathways4 lines with one shared WT10480 cells; 4 pseudobulks · line-specific descriptive effects
Direct projection heterogeneity95.8% · Q 47.44Pooled ρ -0.0178 · source direction not consistent
Cascade projection heterogeneity96.4% · Q 55.07Pooled ρ 0.0324 · source direction not consistent
DMD-correction alignmentρ -0.22591,320 pathways · contextual alignment, not candidate validation.
Bridge projection stateABSTAIN OR VALIDATE IN DMD PERTURB SEQL2 CROSS CONTEXT NETWORK HYPOTHESIS ONLY · does not override the governed current action or create a rank.
Why the workflow abstains
  • weak split half measurement
  • disease source projection inconsistent
  • correction alignment not positive

Pathways overlap and the three source vectors are not independent studies. HepG2 cell-level statistics support source-context exploration only. The disease-matched functional-validation gate remains open.

What this candidate is for

Does the DDX19B evidence pattern survive an independent dataset and frozen analysis workflow?

A candidate record authorizes a bounded question and next experiment. It does not authorize a therapeutic or clinical claim.

GAP-07
Practical useDecide whether the computational signal is reproducible enough to justify experimental escalation.
Decision available nowExperimental escalation remains provisional until the signal is independently reproduced.
What blocks itIndependent computational replication is absent
Minimum next actionRepeat the DDX19B analysis with frozen mapping, contrasts, baselines, null controls and uncertainty reporting.
How would the result change the decision?

SupportiveRetain the candidate and move to its next context-specific gate if direction and uncertainty reproduce.

NullRetain the negative result and do not escalate from the original analysis alone if replication fails with adequate QC.

Inconclusive / QC failureMark the replication non-evaluable when coverage, mapping or source design prevents a fair test.

Gene Entity Page 2.1

Entity graph: identity, evidence and prospective objects

This chain shows which objects exist for DDX19B, which are still drafts and which registries are empty. Empty is not a negative experimental result.

v1.2.0-measured-dmd-evidence
Object IDGENE:v1.2.0-measured-dmd-evidence:DDX19B
HGNCHGNC:2742
EnsemblENSG00000157349
NCBI Gene11269
Disease scopeDMD evidence context
01 · Gene objectRELEASEDStable identity and typed core record
02 · Evidence objectObserved · context-boundedNo DMD perturbation truth is implied
03 · Model gateR2 · R2 · muscle-context bridge evidencePredictionReadiness governance state
04 · Study objectDRAFT · editableCandidate Study Card available
05 · Prediction objectEMPTYNo immutable prospective prediction
06 · Outcome objectEMPTYNo linked measured outcome

Claim boundary: object connectivity improves traceability; it does not raise the evidence tier or authorize a therapeutic claim.

Gene visual profile · 基因证据剖面

One-page evidence profile for DDX19B

A four-panel, descriptive view of the same bounded gene record: evidence depth, DMD source matrix, context gauges and the current decision gap. No score, target rank or prediction claim is computed.

a

Evidence profile

  1. L1 resourceStable record released
  2. L2 HepG2 perturbationassessed
  3. L3a external screenAssessed · no current hit
  4. L3b independent replicationNot assessed
  5. L4 DMD / muscle validationMissing
  6. L5 therapeutic / clinicalUnsupported
b

DMD source matrix

sc baseline pseudobulkPositive source directionMedian effect +0.22745 · signed score 0.00000697observed expression · 17 contexts · 0/17 significant rows
sc delta/DIDNegative source directionMedian effect -0.215494 · signed score -0.00000506observed expression · 18 contexts · 0/18 significant rows

Observed-expression and regulatory-inference channels are displayed side by side and are not pooled as independent cohorts.

c

Context gauges

Source agreement1/2 sources
This measures agreement among source pipelines; it is not biological ground truth.
Muscle expression7.229 TPM
Visual guide; ≥1 TPM is the current triage threshold.
Cells contributing to the aggregate145
Coverage count, not a power calculation.
External screenAssessed · no current hit
This no-hit result is specific to the fusion-screen endpoint; it does not show that the gene has no muscle function.
d

Gap ladder

GAP-07Independent computational replication is absent
  1. Current actionComputational replication
  2. Highest missing layerL4 dmd functional validation
  3. Claim boundaryNo P1/P2 prediction claim unlocked

Interpretation boundary: this visual profile reorganizes frozen fields for inspection. It does not create a source-balanced successor result, a causal conclusion, a therapeutic direction or a clinical decision-support claim.

Decision boundary

What must be resolved next

Decision-blocking gapGAP-07 · Independent computational replication is absent
Highest missing layerL4 dmd functional validation
Readiness upgrade requiredRun an independent DMD/control myogenic perturbation with predeclared molecular, state and functional endpoints.

The decision-blocking gap is the next missing layer that prevents the current action from advancing. The highest missing layer is the longer-term evidence ceiling; it is not necessarily the next experiment.

DMD context

Source-state record

DMD source-state fields for DDX19B
Direction stateconflicted
Variant stabilitysign varied across variants
Evidence modulesdirection conflicted
Statistical supportdirection only no significant context rows
Coverage2 of 4 sources
Uncertaintydirection conflict retained

Identifiers and context

Machine-resolvable core

Machine-resolvable identifiers and context for DDX19B
HGNCHGNC:2742
EnsemblENSG00000157349
NCBI Gene11269
HepG2 perturbationassessed
HepG2 observed cells145
Observed counteralignment0.01813225
Myoblast screenassessed
Myoblast fusion-screen effect0.069099 log fold-change
Myoblast fusion-screen FDR0.999999
Skeletal-muscle expression7.22865 TPM
DepMap median gene effect-0.21244038

Cite this record

Stable identity

Object ID: GENE:v1.2.0-measured-dmd-evidence:DDX19B

NMD-VCell. DDX19B evidence record. Resource v1.2.0-measured-dmd-evidence; evidence freeze 2026-08-03; schema 1.1; build EA-20260817-57. DOI pending.